Corvus Pharmaceuticals
CRVS
#6513
Rank
โ‚ฌ0.74 B
Marketcap
8,82ย โ‚ฌ
Share price
-3.40%
Change (1 day)
18.46%
Change (1 year)

Earnings for Corvus Pharmaceuticals (CRVS)

Earnings in 2026 (TTM): -โ‚ฌ46.71 Million

According to Corvus Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚ฌ13.94 Million, an increase over its 2024 earnings that were of -โ‚ฌ56.79 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corvus Pharmaceuticals from 2015 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ46.71 Million235.26%
2025 -โ‚ฌ13.94 Million-75.47%
2024 -โ‚ฌ56.79 Million130.47%
2023 -โ‚ฌ24.64 Million-34.57%
2022 -โ‚ฌ37.66 Million-4.47%
2021 -โ‚ฌ39.42 Million621.28%
2020 -โ‚ฌ5.47 Million-87.16%
2019 -โ‚ฌ42.55 Million-0.57%
2018 -โ‚ฌ42.79 Million-15.67%
2017 -โ‚ฌ50.75 Million53.03%
2016 -โ‚ฌ33.16 Million16.08%
2015 -โ‚ฌ28.57 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚ฌ0.15 Billion 188.45%๐Ÿ‡บ๐Ÿ‡ธ USA